The Chicago Entrepreneur

[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-light"]
Menu
Top Stories

Novo Nordisk blames middlemen in U.S. healthcare system for high prices of weight loss drugs Wegovy and Ozempic

In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy

Previous post These companies are expected to be the fastest earnings growers in the S&P 500’s cheapest sector
Next post S&P 500’s ‘relentless run’ puts U.S. stocks in ‘rarefied’ territory, this chart shows

More Stories